Hyperuricemia, characterized by elevated levels of serum uric acid (SUA), is linked to a
spectrum of commodities such as gout, cardiovascular diseases, renal disorders, metabolic …

Serum uric acid (SUA) is significantly elevated in obesity, gout, type 2 diabetes mellitus, and
the metabolic syndrome and appears to contribute to the renal, cardiovascular and …

Pulmonary hypertension (PH) is a progressive lethal disease, which is characterized by
abnormal vascular remodeling and persistently elevated pulmonary artery pressure …

Previous studies have suggested an association between uric acid (UA) and the severity of
pulmonary arterial hypertension (PAH), but it is unknown whether UA contributes to disease …

Background Serum uric acid (UA) has long been identified as a prognostic factor of adverse
outcomes in pulmonary hypertension. However, there remains a paucity of evidence on …

Background Observational studies have suggested a correlation between hyperuricemia
and pulmonary arterial hypertension (PAH), yet the causal relationship remains uncertain …

Pulmonary hypertension is a rare, ostensibly incurable, and etiologically diverse disease
with an unacceptably high 5-year mortality rate (≈ 50%), worse than many cancers …

To evaluate the association of uric acid (UA) with adverse outcomes and its potential
mediator in patients with left ventricular diastolic dysfunction (LVDD) and pulmonary …

Background Pulmonary hypertension (PH) is a critical health issue marked by high blood
pressure in the pulmonary arteries, with limited data on its clinical characteristics in the …

Systemic sclerosis (SSc) is an immuno-inflammatory rheumatic disease that can affect both
the skin and internal organs through fibrosis. Pulmonary arterial hypertension (PAH) is one …